CSIMarket Company Name, Ticker, Competitors, else..
 
Prothena Corporation Public Limited Company  (NASDAQ: PRTA)
 
Price: $9.5400 $-0.28 -2.851%
Day's High: $9.670000076293945 Week Perf: -0.73 %
Day's Low: $ 9.35 30 Day Perf: 8.9 %
Volume (M): 305,057 52 Wk High: $ 11.80
Volume (M$): $ 0 52 Wk Avg: $9.54
Open: $9.60 52 Wk Low: $7.73



 Market Capitalization (Millions $) 497
 Shares Outstanding (Millions) 52
 Employees 67
 Revenues (TTM) (Millions $) 55
 Net Income (TTM) (Millions $) -44
 Cash Flow (TTM) (Millions $) -42
 Capital Exp. (TTM) (Millions $) 1

Business Description


Prothena Corporation Public Limited Company is a biotechnology company that specializes in developing and commercializing therapies for neurodegenerative diseases. The company focuses on creating drugs that target the misfolding and accumulation of proteins, which are believed to play a role in diseases like amyloidosis, Parkinson's disease, and Alzheimer's disease. Prothena's research and development efforts are centered around antibody-based therapies, with the goal of preventing or slowing the progression of these diseases. The company is headquartered in Dublin, Ireland, and is publicly traded on the NASDAQ stock exchange.


   Company Address: 77 Sir John Rogerson’s Quay, Block C Dublin 2, 0
   Company Phone Number: 236-2500   Stock Exchange / Ticker: NASDAQ PRTA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IONS   -6.05%    
ONC   -2.25%    
RPRX   -1.34%    
TEVA        1.97% 
VRTX   -2.87%    
VTRS        0.61% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 9.12
Price to Sales (Expected) -
Price to Book 1.73
PEG (TTM) -

Financial Strength Current
Quick Ratio 24.72
Working Capital Ratio 25.15
Leverage Ratio (MRQ) 0.16
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.84 $
Revenues (TTM) 1.05 $
Cash Flow (TTM) -
Cash 5.53 $
Book Value 5.5 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 813,881
Net Income per Employee (TTM) -656,597
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.16

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -2089.21 %
Net Margin (MRQ) -1839.9 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Prothena Public Limited's Segments
Collaboration    202.38 % of total Revenue
License    4955.45 % of total Revenue
Collaboration Program, Global, Prx019    99.01 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.